Table III.

Demography and clinical characteristics of the co MG-PD group.

First author, year	Sex	Age at diagnosis of PD/MG, years	Comorbidities	MG antibodies	Ocular symptoms	Dysphagia	Dysarthria	Head drop	(Refs.)
Albassam, 2021	F	72/72	HPT, DM, dyslipidemia	AChR: N; MuSK: P	Y	Y	N	N	(28)
Alshaikh, 2021	M	78/-	Thyroid disease	AChR: P	Y	N	N	N	(4)
Alshaikh, 2021	M	60/-	Neuropathy, vitamin B12 deficiency, CVID	AChR: P	Y	Y	Y	N	(4)
Alshaikh, 2021	M	-/-	Thyroid disease, hemophilia A	AChR: P	Y	Y	Y	N	(4)
Alshaikh, 2021	M	84/-	Thyroid disease	AChR: P	NR	NR	NR	NR	(4)

F, female; M, male; PD, Parkinson's disease; MG, myasthenia gravis; AChR, acetylcholine receptor; MuSK, muscle-specific kinase; NR, not reported; CVID, common variable immunodeficiency; -, unknown; P, positive; NeY, yes; N, No.